ResMed (RMD) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $203.87 -2.2%
EPS Growth %: +13.3%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +13.3%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.66, $0.06 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.03 million versus the consensus estimate of $990.85 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Delta Air shares slip despite strong outlook, Melius says
- Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
